週次 |
日期 |
單元主題 |
第1週 |
2/23 |
Introduction |
第2週 |
3/01 |
PK of Intravascular Administration-One Compartment Model |
第3週 |
3/08 |
PK of Oral Adsorption |
第4週 |
3/15 |
PK of Intravenous Infusion |
第5週 |
3/22 |
Drug Distribution and Protein Binding |
第6週 |
3/29 |
Biopharmaceutic Considerations in Drug Product Design |
第7週 |
4/05 |
溫書假 |
第8週 |
4/12 |
Bioavailability & Bioequivalence |
第9週 |
4/19 |
期中考 |
第10週 |
4/26 |
Elimination of Drugs and Pharmacogenetics (Chapters 6, 11 and 12) |
第11週 |
5/03 |
Nonlinear Pharmacokinetics and protein binding (Chapters 9 and 10) |
第12週 |
5/10 |
Multiple dosage regimens (Chaper 8) |
第13週 |
5/17 |
Application of pharmacokinetics in clinical situations (Chapter 20) |
第14週 |
5/24 |
Dose adjustment in renal and hepatic disease (Chapter 21) |
第15週 |
5/31 |
Physiological pharmacokinetics and noncompartment approach (Chapter 22) |
第16週 |
6/07 |
Relationship between pharmacokinetics and pharmacodynamics (Chapter 19) |
第17週 |
6/14 |
溫書假 |